Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 25.28 is 585% above its 5-year average of -5.21, near the high end of its 5-year range (-100.50–33.55).
136.70% above its 12-month average of 10.68.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 9.58.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:57:27.146Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
25.28
EARNINGS PER SHARE (EPS) AVG TTM
10.68
EARNINGS PER SHARE (EPS) AVG 3Y
-22.38
EARNINGS PER SHARE (EPS) AVG 5Y
-5.21
EARNINGS PER SHARE (EPS) AVG 10Y
-2.73
EARNINGS PER SHARE (EPS) AVG 15Y
5.85
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+136.70%
CURRENT VS 3Y AVG
+212.95%
CURRENT VS 5Y AVG
+584.76%
CURRENT VS 10Y AVG
+1025.10%
CURRENT VS 15Y AVG
+331.83%
CURRENT VS 20Y AVG
N/A
Nutex Health, Inc.
Market Cap
$1.54B
Earnings Per Share (EPS)
25.28
TTM Avg
10.68
3Y Avg
-22.38
5Y Avg
-5.21
Market Cap
$1.54B
Earnings Per Share (EPS)
-4.04
TTM Avg
-4.19
3Y Avg
-4.39
5Y Avg
-2.20
Market Cap
$1.54B
Earnings Per Share (EPS)
4.10
TTM Avg
2.19
3Y Avg
2.59
5Y Avg
2.64
Market Cap
$1.51B
Earnings Per Share (EPS)
0.38
TTM Avg
-0.16
3Y Avg
-0.18
5Y Avg
-0.35
Market Cap
$1.50B
Earnings Per Share (EPS)
2.44
TTM Avg
1.82
3Y Avg
1.13
5Y Avg
1.18
Market Cap
$1.49B
Earnings Per Share (EPS)
-1.00
TTM Avg
-0.77
3Y Avg
-0.59
5Y Avg
-0.43
Market Cap
$1.49B
Earnings Per Share (EPS)
-3.04
TTM Avg
-3.32
3Y Avg
-2.31
5Y Avg
-2.31
Market Cap
$1.48B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.60B
Earnings Per Share (EPS)
0.84
TTM Avg
0.16
3Y Avg
0.00
5Y Avg
0.42
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutex Health, Inc. (NUTX) | $1.54B | 25.28 | 10.68 | -22.38 | -5.21 |
| uniQure N.V. (QURE)vs › | $1.54B | -4.04 | -4.19 | -4.39 | -2.20 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 4.10 | 2.19 | 2.59 | 2.64 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 0.38 | -0.16 | -0.18 | -0.35 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 2.44 | 1.82 | 1.13 | 1.18 |
| GH Research PLC (GHRS)vs › | $1.49B | -1.00 | -0.77 | -0.59 | -0.43 |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | -3.04 | -3.32 | -2.31 | -2.31 |
| Certara, Inc. (CERT)vs › | $1.48B | -0.44 | -0.04 | -0.09 | -0.12 |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 0.84 | 0.16 | 0.00 | 0.42 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$25.28
Forward EPS (Est.)
$27.79
P/E Ratio
8.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 11.13 |
| 2024-12-31 | 10.23 |
| 2023-12-31 | -10.39 |
| 2022-12-31 | -100.50 |
| 2021-12-31 | 33.55 |
| 2020-12-31 | 24.69 |
| 2019-12-31 | 4.88 |
| 2018-12-31 | -0.02 |
| 2017-12-31 | -0.07 |
| 2016-12-31 | -3.60 |
| 2015-12-31 | 0.04 |
| 2014-12-31 | -2250.00 |
| 2013-12-31 | 750.00 |
| 2012-12-31 | -5250.00 |
| 2011-12-31 | -0.32 |
| 2010-12-31 | 0.13 |
| 2009-12-31 | 0.53 |
| 2008-12-31 | 1500.00 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T15:57:27.146Z. Historical observations retain their original dates. Historical series through 2022-03-31.
